Calico Life Sciences

Calico Life Sciences LLC is a biotechnology research and development company based in South San Francisco, California. Founded in 2013 and a subsidiary of Alphabet Inc., Calico focuses on understanding the biology of aging and lifespan. The company aims to develop interventions that promote longer, healthier lives through basic research into aging biology, utilizing advanced technologies and interdisciplinary approaches. Calico employs around 200 professionals, including scientists and engineers, fostering a culture of innovation and collaboration. The company holds 44 patents related to transcription factors, proteins, and gene expression. Its research includes a drug-development pipeline targeting age-related conditions, with recent highlights such as FDA designations for investigational treatments for specific diseases. Calico actively seeks partnerships with biopharma and academic institutions to enhance its research efforts in aging and related health issues.